2月24日 - ** 券商Benchmark将医院运营商选择医疗SEM.N的评级从 "持有 "上调至 "买入"。
** 经纪商将目标价定为 23 美元，理由是第四季度业绩强劲，而且由于加速住院康复床位的前期成本，预测较为保守。
** Benchmark称，SEM专注于扩大其利润率最高的住院康复部门，有望推动长期盈利能力的提高
** 我们认为长期急症护理医院(LTACH) 今年的收入可能会随着商业合同的谈判和病人数量的增加而有所改善。
** 根据 LSEG 编制的数据，5 家覆盖该股的券商的 PT 中位数为 23 美元。
** 今年以来股价下跌 5.9
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.